What pharma investors ought to do after Donald Trump fires a salvo By: MarketWatch January 11, 2017 at 15:14 PM EST Reduce exposure to those industries on fears of a drug-price crackdown, says Nigam Arora. Read More >> Related Stocks: Bristol-Myers Squibb Eli Lilly Johnson & Johnson Merck & Co Nasdaq Biotechnology Ishares ETF Pfizer S&P Biotech SPDR S&P Pharmaceuticals SPDR US Pharmaceuticals Ishares ETF Ultrashort Nasdaq Biotechnology -2X ETF Vaneck Biotech ETF Vaneck Pharmaceutical ETF
